Medical Technologies Program

Up to 250 hours of research through the Medical Technologies Program to develop new medical devices and assistive technologies.

Medical Technologies Program

Medical Technologies Program

The Medical Technologies Program supports the early stage development of new commercially viable medical and assistive devices through collaboration between industry, researchers, end-users and government.

Participants in the MTP receive up to 250 hours of research to assist with any stage of the research and development process, and may include prototype development, proof of concept work, product validation or evaluation, as well as a 30 hour market assessment.



The Medical Technologies Program (MTP) is part of the Medical Device Partnering Program (MDPP).

The Medical Device Partnering Program (MDPP) is an ideas incubator. They foster collaborations between researchers, industry, end-users and government and develop medical technologies with global market potential.

Led by Professor Karen Reynolds of Flinders University, the Program provides a mechanism to develop proof of concept, prototyping, clinical evaluation and commercialisation planning.

Previously funded MTP projects include the design and development of a ventilator prototype, the development of a new tool to help treat atrial fibrillation patients, the design of a dental x-ray device and the assessment of a bed frame to help people move from sitting to standing.



To receive support through the Medical Technologies Program (MTP), proposals must:

  • create or improve a medical device or assistive technology
  • be technically and commercially feasible
  • involve innovation
  • be able to be completed within 250 hours or three months
  • be proposed by a company, commercial enterprise or individual who agrees to form an entity with a current or proposed connection in South Australia.

The proposing business or individual must be able to co-contribute $5,000 (ex GST) to the project.

The MTP supports projects with an identified clinical need, sound technical solution and viable market opportunity.



Applications open on an ongoing basis.


More Information

  • Source

What is the #1 grant for start-ups?

12,000+ companies access the R&D tax incentive per year that yields a CASH REBATE of up to 43.5%.
This might be perfect your start up.
Do you want to know more?

Scroll to Top
R&D Top 10 Consultant Tips

Top 10 Consultant Tips to Maximise the R&D Tax Incentive